Hoyeraal Hreidarsson SyndromeSymptoms, Doctors, Treatments, Advances & More
Hoyeraal Hreidarsson Syndrome Overview
Learn About Hoyeraal Hreidarsson Syndrome
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
University Hospitals
Kord Honda is a Dermatologist practicing medicine in Cleveland, Ohio. Dr. Honda is rated as an Advanced provider by MediFind in the treatment of Hoyeraal Hreidarsson Syndrome. He is also highly rated in 79 other conditions, according to our data. His clinical expertise encompasses Melanoma, Erythroderma, Hereditary Mucoepithelial Dysplasia, and Stiff Skin Syndrome. Dr. Honda is currently accepting new patients.
Bassett Health Center Norwich
Jennifer O'reilly is a primary care provider, practicing in Internal Medicine in Norwich, New York. She has been practicing medicine for over 18 years. Dr. O'reilly is rated as an Experienced provider by MediFind in the treatment of Hoyeraal Hreidarsson Syndrome. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Ringworm, Maturity Onset Diabetes of the Young, Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. O'reilly is currently accepting new patients.
Indian River Health Services Inc
Jonathan Braue is a Dermatologist practicing medicine in Vero Beach, Florida. Dr. Braue is rated as an Experienced provider by MediFind in the treatment of Hoyeraal Hreidarsson Syndrome. He is also highly rated in 56 other conditions, according to our data. His clinical expertise encompasses Sunburn, Actinic Keratosis, Warts, and Seborrheic Keratosis. Dr. Braue is board certified in American Board Of Dermatology, 2019. Dr. Braue is currently accepting new patients.
Summary: The goal of this clinical trial is to learn if a combination therapy of deoxycytidine (dC) plus deoxythymidine (dT) is safe in patients with telomere biology disorders. The main questions it aims to answer are: * Is the therapy safe with tolerable side effects in patients with telomere biology disorders? * Are problems with the bone marrow or blood or lungs changed after 6 months of dC+dT treatmen...
Summary: Phase II prospective trial to assess the rates of donor engraftment using reduced intensity conditioning (RIC) hematopoietic stem cell transplant (HSCT) and post-transplant cyclophosphamide (PTCy) for patients with primary immune deficiencies (PID), immune dysregulatory syndromes (IDS), inherited bone marrow failure syndromes (IBMFS), short telomere syndromes, Fanconi anemia, and non-Fanconi DNA d...

